MicroVision's SEC filings document material events for a lidar-based perception company serving automotive, industrial, and security and defense markets. Current reports describe operating results, business updates, investor presentations, and product and market disclosures tied to the company's lidar sensor portfolio and perception software.
Recent filings also record the completed acquisition of certain Luminar lidar sensor business assets, including required historical financial statements and unaudited pro forma financial information. Other disclosures cover senior secured convertible notes due 2028, exchanges and purchases of convertible debt, direct common stock sales to directors and executive officers, Nasdaq-related share issuance considerations, governance matters, and Regulation FD communications.
MicroVision (MVIS) CFO equity activity: Chief Financial Officer Anubhav Verma reported the vesting of restricted stock units and related share activity. On 11/17/2025, 16,765 restricted stock units vested and were converted into the same number of common shares at an exercise price of $0.00. On 11/18/2025, 4,225 common shares were disposed of at $0.941 per share in a tax withholding "sell-to-cover" transaction completed by the company under the award terms.
Following these transactions, Verma beneficially owned 499,438 shares of MicroVision common stock in direct ownership, and no restricted stock units remained from this specific award. The filing notes that the RSUs were distributed on a one-for-one share basis and that the tax sale was nondiscretionary, carried out in accordance with the award agreement.
MicroVision, Inc. filed a current report to inform investors that it has released its third quarter 2025 financial results. On November 11, 2025, the company issued a press release detailing these results, which is attached to the report as Exhibit 99.1 and incorporated by reference. The company notes that the information is being furnished rather than filed under securities laws, which affects how it is treated for legal liability purposes but still makes the earnings information available to the market.
MicroVision, Inc. reporting person Simon Biddiscombe, an Executive Vice Chair and Director, received a grant of 241,000 restricted stock units (RSUs) on 10/01/2025. The RSUs convert unit-for-share at vesting with no cash payment required, and are scheduled to vest in full on 10/01/2026 provided the reporting person continues service through that date. The Form 4 discloses the transaction date as 10/01/2025 and the filing was signed by an attorney-in-fact on 10/02/2025. The report records direct beneficial ownership of 0 common shares following the grant because the RSUs have not yet vested.
MicroVision, Inc. is making a planned leadership change, promoting current Chief Technology Officer Glen W. DeVos to President and Chief Executive Officer and to the Board, effective September 30, 2025. Current CEO Sumit Sharma will serve until that date, after which his removal qualifies as an involuntary termination under the company’s Executive Severance and Change in Control Plan, entitling him to severance upon signing a customary release.
Under a new employment agreement, Mr. DeVos will receive a $530,000 annual base salary, a short-term incentive opportunity equal to 100% of base salary, and a grant of 539,000 RSUs that vest on June 6, 2026 only if specified company and individual objectives are met. The Board plans to set a longer-term equity structure for him in 2026. The Board also named director Simon Biddiscombe as Executive Vice Chair for up to 12 months, with a $265,000 salary and 241,000 RSUs vesting October 1, 2026. During this period he will not be an independent director, and Robert Carlile will become Audit Committee Chair.
MicroVision, Inc. (MVIS) director Jada Smith received 22,007 shares when restricted stock units (RSUs) vested on 09/02/2025 and were distributed on a unit-for-share basis without payment. After the distribution, the reporting person beneficially owned 82,344 shares of common stock directly. The Form 4 also discloses RSUs granted 06/06/2025 that vest in four equal quarterly installments through the earlier of the first anniversary of the grant or the day before the 2026 annual meeting, subject to continued service as a director.
MicroVision director Peter Schabert received 22,007 shares when vested restricted stock units converted to common stock on 09/02/2025. The shares were distributed at $0.00 as vested RSUs convert on a unit-for-unit basis without payment. After the transaction Schabert beneficially owned 102,457 shares. The filing corrects an earlier RSU grant reporting error, noting the original Form 4 misreported totals and that the vesting disclosed here was calculated using a stated “correct” RSU amount. The Form 4 was signed by an attorney-in-fact on behalf of Schabert.
Laura J. Peterson, a director of MicroVision, Inc. (MVIS), received 18,006 shares of MicroVision common stock on 09/02/2025 when vested restricted stock units (RSUs) converted to shares on a unit-for-unit basis with no cash payment. After the transaction the reporting person beneficially owns 18,006 shares directly. The Form 4 indicates these shares resulted from RSUs granted on 06/06/2025 that were scheduled to vest in four equal quarterly installments and convert to common stock at vesting.
Jeffrey A. Herbst, a director of MicroVision, Inc. (MVIS), received 22,007 shares of common stock on 09/02/2025 upon vesting of restricted stock units (RSUs). The RSUs converted on a one-for-one basis into common shares at no cash payment, increasing His beneficial ownership to 186,713 shares following the transaction. The filing corrects an earlier grant reporting error: the original Form 4 filed 06/06/2025 misstated the total RSUs granted; the correct total used for vesting calculations is 88,028 RSUs.
This Form 4 reports a routine equity compensation vesting event for a director and does not disclose any sale or cash proceeds. The transaction was reported on 09/03/2025 by an attorney-in-fact signing for the reporting person.
MicroVision, Inc. director Robert Paul Carlile received 22,007 shares of common stock on 09/02/2025 when restricted stock units vested and were distributed on a unit-for-share basis at no cost. After the distribution, Mr. Carlile beneficially owned 306,785 shares of MicroVision common stock. The Form 4 corrects a prior grant reporting error: an earlier filing misreported the total RSUs granted in June 2025, and this filing explains the vesting calculation used for the distributed shares.
MicroVision director Simon Biddiscombe received 22,007 shares of common stock on 09/02/2025 when restricted stock units (RSUs) vested and converted to shares on a unit-for-unit basis with no payment required. After the distribution, the reporting person beneficially owned 247,285 shares. The filing corrects an earlier Form 4 that misstated the total RSUs granted in June 2025; the correct grant amount was 88,028 RSUs, and the vesting here reflects that corrected figure. The transaction was reported by an attorney-in-fact on 09/03/2025.